A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy - United States
doi 10.1038/mt.2013.79
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2013
Authors
Publisher
Elsevier BV